ability of prospectively designed randomized trials to provide
unbiased, definitive evidence about the benefits and risks of
treatments in the population studied is not in doubt, certain critical
aspects of drug therapy, however, cannot be addressed by this method or
addressed as rapidly as physicians, patients, and the public would
like. In this issue of THE JOURNAL, 2 related
articles1,2 consider the potential value of other methods
of discovery of adverse consequences of drug use as well as the
beneficial effects of drugs, specifically through epidemiologic methods
and meta-analyses (systematic overviews) of data. These methods
unquestionably have a place in the assessment of drug treatments but,
as has been often pointed out, they must be used with care and
recognition of their limitations.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 50
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.